title: Legal. PCTs taken to court over use of cheaper drug.
authors: sarah.calkin@emap.com
authors: Sarah
authors: S
authors: Calkin
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000068258:Bevacizumab; D017046:Cost Savings / Q000331:legislation & jurisprudence / Q000592:standards; D057915:Drug Substitution / Q000191:economics / Q000592:standards*; D006801:Humans; D061214:Patient Safety / Q000191:economics / Q000331:legislation & jurisprudence*; D011320:Primary Health Care / Q000191:economics / Q000331:legislation & jurisprudence*; D000069579:Ranibizumab; D013222:State Medicine / Q000191:economics / Q000331:legislation & jurisprudence; D006113:United Kingdom; D057135:Wet Macular Degeneration / Q000188:drug therapy / Q000191:economics
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab